Screening for Lipid Disorders in Children and Adolescents: US Preventive Services Task Force Recommendation Statement

JAMA. 2023 Jul 18;330(3):253-260. doi: 10.1001/jama.2023.11330.

Abstract

Importance: Familial hypercholesterolemia and multifactorial dyslipidemia are 2 conditions that cause abnormally high lipid levels in children, which can lead to premature cardiovascular events (eg, myocardial infarction and stroke) and death in adulthood.

Objective: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for lipid disorders in asymptomatic children and adolescents.

Population: Asymptomatic children and adolescents 20 years or younger without a known diagnosis of a lipid disorder.

Evidence assessment: The USPSTF concludes that the current evidence is insufficient and the balance of benefits and harms for screening for lipid disorders in asymptomatic children and adolescents 20 years or younger cannot be determined.

Recommendation: The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger. (I statement).

Publication types

  • Research Support, Non-U.S. Gov't
  • Systematic Review

MeSH terms

  • Adolescent
  • Advisory Committees
  • Asymptomatic Diseases
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control
  • Child
  • Dyslipidemias* / complications
  • Dyslipidemias* / diagnosis
  • Dyslipidemias* / therapy
  • Humans
  • Lipids
  • Mass Screening* / adverse effects
  • Mass Screening* / methods
  • Preventive Health Services
  • Risk Assessment
  • Young Adult

Substances

  • Lipids